Perrigo | PRGO - 負債





負債 変化する 日付
AbbVie USD 67.5B 67.5B 2025-12
Abbott USD 13.86B 919M 2025-12
Bayer EUR 36.45B 2.93B 2025-12
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Coherus Biosciences USD 294.92M 1.25M 2025-03
Corcept Therapeutics USD 6.11M 251K 2025-12
Dr.Reddys Laboratories INR 67.73B 9.19B 2025-12
Eli Lilly USD 42.5B 3.6M 2025-12
J&J USD 47.93B 2.14B 2025-12
Merck USD 49.34B 7.97B 2025-12
Nestle CHF 54.31B 285M 2022-12
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.64B 4.5M 2025-12
Pfizer USD 63.73B 231M 2026-03
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.08B 38.27M 2025-12
Reckitt Benckiser GBP 8.66B 238M 2024-12
Sanofi EUR 20.33B 1.43B 2025-12
Supernus Pharmaceuticals USD 40.98M 1.23M 2025-12
Teva Pharmaceutical Industries USD 17.09B 21M 2025-12
Xeris Pharmaceuticals USD 257.65M 431K 2025-09
Zoetis USD 9.24B 1.96B 2025-12